This inventor holds 1 USPTO granted patent. Top assignees: Johns Hopkins University, Synthelabo. Active years: 1988.
Company Filing History:
1 out of 3,795 
1 out of 252 Years Active: 1988
Title: Claude Bordat: Innovator in Nutritional Supplements
Introduction
Claude Bordat is a notable inventor based in Dordives, France. He has made significant contributions to the field of nutritional supplements, particularly in the treatment of uremia. His innovative approach has led to the development of a unique patent that addresses chronic renal failure.
Latest Patents
Bordat holds a patent for a nutritional supplement designed for the treatment of uremia. This patent, titled "Nutritional supplement for treatment of uremia," focuses on mixtures of mixed salts formed between branched-chain alpha keto-acids and basic L-amino acids. These compositions are beneficial in the nutritional treatment of chronic renal failure, offering a solution that contains fewer component salts compared to other mixtures. The compositions can be effectively used alongside a 20-30 g/day mixed quality protein diet, along with a vitamin and mineral supplement.
Career Highlights
Throughout his career, Claude Bordat has worked with prestigious institutions, including The Johns Hopkins University and Synthelabo. His experience in these organizations has contributed to his expertise in nutritional science and innovation.
Collaborations
Bordat has collaborated with notable individuals in his field, including Mackenzie Walser and Henri Bermudez. These partnerships have further enhanced his research and development efforts in nutritional supplements.
Conclusion
Claude Bordat's contributions to the field of nutritional supplements, particularly through his patent for treating uremia, highlight his innovative spirit and dedication to improving health outcomes. His work continues to influence the nutritional treatment of chronic renal failure.